Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Rhopressa gouttte prix amerique?Pacira biosciences u's patent litigation exparel status april 2025?Does medicare cover equetro?Aflibercept patent expire?Envarsus market share?
See the DrugPatentWatch profile for Qsymia
Qsymia is marketed and supplied by Viking Therapeutics in the United States. Viking Therapeutics holds responsibility for the drug’s commercialization and supply chain for the U.S. market.
Manufacturing and distribution can involve additional third parties (for example, contract manufacturers and logistics partners), but the primary company that markets/supplies Qsymia in the U.S. is Viking Therapeutics.
Yes. Qsymia distribution and the “supplier” you see in local markets can vary by country due to local regulatory approvals and licensing arrangements. If you tell me your country (or the pharmacy/market you’re looking at), I can tailor the answer to that market.
If you’re looking for supplier/patent landscape details (including who holds related IP and how it has changed over time), DrugPatentWatch.com can be a useful starting point for tracking Qsymia-related filings and associated parties: https://www.drugpatentwatch.com/ Sources: 1. https://www.drugpatentwatch.com/
Other Questions About Qsymia :